NYSE : DGX

Quest Diagnostics Incorporated

$231.84 USD

$3.98 (1.75%)

Volume
959.71K
Average Volume
920.83K
Market Capitalization
$25.59B
P/E Ratio
24.30
Dividend Yield
1.43%
Price Target
$235.00
Year High
$237.78
Year Low
$165.78
Day High
—
Day Low
—
Payout Ratio
$0.34
Current Ratio
$1.59
Company Overview

NYSE

James E. Davis

Medical - Diagnostics & Research

Healthcare

DGX

57000

US

USD

https://www.questdiagnostics.com

973 520 2700

74834L100

0001022079

Liquidity Metrics

0.85

1.59

1.46

0.35

0.34

Sales & Valuation

$11.04B

2.21

3.39

20.97

11.09

Profitability

$8.75

$992M

9.19%

12.28%

14.49%

6.27%

P/E Metrics

24.30

1.92

1.92

Analyst Price Target & Rating

$235.00

$255.00

$220.00

Neutral

3/5

34 Analysts

-1.34%

Financial Health Scores

3.59

7/9

$1.06B

$16.94B

$9.12B

$1.65B

Key Metrics (TTM)

$30.91B

2.67

15.39

1.59

14.49%

8.25%

4.24%

4.85%

$121.83

64 days

Company Executives
Name Title
Michael J. Deppe Senior Vice President, Corporate Controller & Chief Accounting Officer
Michael E. Prevoznik Senior Vice President & General Counsel
Catherine T. Doherty Executive Vice President of Regional Businesses
Sam A. Samad Executive Vice President & Chief Financial Officer
Dan Haemmerle Interim VP of Investor Relations & VP Finance
Garry Clark Senior Vice President and Chief Marketing & Communications Officer
Murali Balakumar Senior Vice President and Chief Information & Digital Officer
Kristin Lee Wallace Senior Vice President & Chief Compliance Officer
James E. Davis Chairman, Chief Executive Officer & President
Karthik Kuppusamy Senior Vice President of Clinical Solutions
Poll Results

No votes yet today — be the first to share your view!

About Quest Diagnostics Incorporated (NYSE:DGX) Stock

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated thro ... ugh a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

Why Quest Diagnostics Stock Climbed This Past Week

2026-07-26 22:02:30

Partnerships with other healthcare leaders are accelerating Quest's growth. AI is making the health insights provider more profitable.

Are You Looking for a Top Momentum Pick? Why Quest Diagnostics (DGX) is a Great Choice

2026-07-24 13:01:09

Does Quest Diagnostics (DGX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term

2026-07-24 10:50:17

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out?

2026-07-24 10:16:22

Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Quest Diagnostics Upgrades EPS Outlook For 2026 After Outperforming Q2 Results

2026-07-24 05:59:11

Quest Diagnostics earns a reiterated buy rating after Q2 earnings beat, upgraded FY guidance, and continued market momentum. DGX benefits from strong macro demand for specialized diagnostic testing, peer-leading ROE, and resilient top-line growth (+10.2% YoY). Upward earnings revisions, robust dividend growth, and investment-grade credit ratings support the bull case, though cost pressures and payor risk warrant monitoring.

Quest Diagnostics Q2 Earnings Call Highlights

2026-07-23 15:08:36

Quest Diagnostics NYSE: DGX reported double-digit revenue growth and raised its full-year 2026 outlook after what executives described as strong demand across its physician, hospital and consumer channels, as well as increased volume from major collaborations with Corewell Health and Fresenius Medical Care.

Quest Diagnostics Incorporated (DGX) Q2 2026 Earnings Call Transcript

2026-07-23 14:30:36

Quest Diagnostics Incorporated (DGX) Q2 2026 Earnings Call Transcript

Americans Are Buying More Preventive Health Tests—and Quest Diagnostics Is Winning

2026-07-23 13:47:15

Quest Diagnostics Incorporated (NYSE:DGX) stock surged Thursday after the diagnostic testing company reported second-quarter results that topped Wall Street expectations and raised its full-year 2026 guidance.

Frequently Asked Questions

What is the current Quest Diagnostics Incorporated (DGX) stock price?

Quest Diagnostics Incorporated(NYSE:DGX) stock price is $231.84 in the last trading session. During the trading session, DGX stock reached the peak price of $237.78 while $165.78 was the lowest point it dropped to. The percentage change in DGX stock occurred in the recent session was 1.75% while the dollar amount for the price change in DGX stock was $3.98.

DGX's industry and sector of operation?

The NYSE listed DGX is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.

Who are the executives of DGX?

Michael J. Deppe | Senior Vice President, Corporate Controller & Chief Accounting Officer
Michael E. Prevoznik | Senior Vice President & General Counsel
Catherine T. Doherty | Executive Vice President of Regional Businesses
Sam A. Samad | Executive Vice President & Chief Financial Officer
Dan Haemmerle | Interim VP of Investor Relations & VP Finance

How many employees does DGX have?

Number of DGX employees currently stands at 57000. DGX operates from 500 Plaza Drive, Secaucus, NJ 07094, US.

Link for DGX official website?

Official Website of DGX is: https://www.questdiagnostics.com

How do I contact DGX?

DGX could be contacted at phone #973 520 2700 and can also be accessed through its website. DGX operates from 500 Plaza Drive, Secaucus, NJ 07094, US.

How many shares of DGX are traded daily?

The average number of DGX shares traded daily for last 3 months was 920.83K.

What is the market cap of DGX currently?

The market value of DGX currently stands at $25.59B with its latest stock price at $231.84